(-)-epigallocatechin 3-gallate multiple interactions ISO SLC51B (Homo sapiens) 6480464 epigallocatechin gallate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of SLC51B mRNA] and epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of SLC51B mRNA] CTD PMID:22178739 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with Ethinyl Estradiol] results in increased expression of SLC51B mRNA CTD PMID:23146761 (R)-pantothenic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Pantothenic Acid results in increased expression of SLC51B mRNA CTD PMID:19397697 1,1-dichloroethene decreases expression ISO Slc51b (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC51B mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Slc51b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC51B mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO Slc51b (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA CTD PMID:19407337 more ... 1-naphthyl isothiocyanate multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] more ... CTD PMID:28549656 more ... 1-naphthyl isothiocyanate multiple interactions ISO SLC51B (Homo sapiens) 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 17alpha-ethynylestradiol multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with Ethinyl Estradiol] results in increased expression of SLC51B mRNA CTD PMID:23146761 17alpha-ethynylestradiol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 17beta-estradiol increases expression ISO SLC51B (Homo sapiens) 6480464 Estradiol results in increased expression of SLC51B mRNA CTD PMID:20106945 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO SLC51B (Homo sapiens) 6480464 2 more ... CTD PMID:20638727 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Slc51b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Slc51b (Mus musculus) 6480464 ESR1 gene mutant form inhibits the reaction [2 more ... CTD PMID:29112739 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Slc51b (Mus musculus) 6480464 2 more ... CTD PMID:29112739 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Slc51b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SLC51B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC51B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc51b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA CTD PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc51b (Mus musculus) 6480464 AHR gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC51B mRNA] CTD PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc51b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC51B mRNA CTD PMID:26377647 3,3',5-triiodo-L-thyronine increases expression ISO SLC51B (Homo sapiens) 6480464 Triiodothyronine results in increased expression of SLC51B mRNA CTD PMID:21815645 3,3',5-triiodo-L-thyronine multiple interactions ISO SLC51B (Homo sapiens) 6480464 (4-(4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl)-3 and 5-dimethylphenoxy)acetic acid inhibits the reaction [Triiodothyronine results in increased expression of SLC51B mRNA] CTD PMID:21815645 4,4'-sulfonyldiphenol decreases expression ISO Slc51b (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC51B mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol increases methylation ISO Slc51b (Mus musculus) 6480464 bisphenol S results in increased methylation of SLC51B promoter CTD PMID:33297965 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC51B mRNA CTD PMID:24780913 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO Slc51b (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of SLC51B mRNA CTD PMID:33749747 aflatoxin B1 increases expression ISO SLC51B (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SLC51B mRNA CTD PMID:21632981 and PMID:21641981 allopurinol multiple interactions ISO Slc51b (Mus musculus) 6480464 [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of SLC51B mRNA CTD PMID:33749747 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of SLC51B mRNA CTD PMID:23912714 arsane decreases expression ISO SLC51B (Homo sapiens) 6480464 Arsenic results in decreased expression of SLC51B mRNA CTD PMID:36861143 arsenic atom decreases expression ISO SLC51B (Homo sapiens) 6480464 Arsenic results in decreased expression of SLC51B mRNA CTD PMID:36861143 atazanavir sulfate multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA CTD PMID:32152650 aztreonam decreases expression ISO Slc51b (Mus musculus) 6480464 Aztreonam results in decreased expression of SLC51B mRNA CTD PMID:24657338 benzo[a]pyrene increases expression ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SLC51B mRNA CTD PMID:21632981 benzo[a]pyrene decreases expression ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC51B mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC51B exon and Benzo(a)pyrene results in increased methylation of SLC51B promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO SLC51B (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC51B 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO SLC51B (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 beta-hexachlorocyclohexane decreases expression ISO Slc51b (Mus musculus) 6480464 beta-hexachlorocyclohexane results in decreased expression of SLC51B mRNA CTD PMID:28392238 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC51B mRNA CTD PMID:25181051 bisphenol A affects expression ISO SLC51B (Homo sapiens) 6480464 bisphenol A affects the expression of SLC51B mRNA CTD PMID:30903817 bosentan increases expression ISO SLC51B (Homo sapiens) 6480464 Bosentan results in increased expression of SLC51B mRNA CTD PMID:29761207 budesonide multiple interactions EXP 6480464 [Budesonide binds to NR3C1 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 budesonide increases expression ISO SLC51B (Homo sapiens) 6480464 Budesonide results in increased expression of SLC51B mRNA CTD PMID:19562681 caffeine increases phosphorylation ISO SLC51B (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of SLC51B protein CTD PMID:35688186 calcitriol decreases expression ISO SLC51B (Homo sapiens) 6480464 Calcitriol results in decreased expression of SLC51B mRNA CTD PMID:19562681 calcitriol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Calcitriol co-treated with Chenodeoxycholic Acid] results in decreased expression of SLC51B mRNA CTD PMID:19562681 carbon nanotube increases expression ISO Slc51b (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of SLC51B mRNA CTD PMID:25620056 cefalotin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA CTD PMID:24657338 CGP 52608 multiple interactions ISO SLC51B (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC51B gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:16423920 more ... chenodeoxycholic acid multiple interactions EXP 6480464 [Chenodeoxycholic Acid binds to NR1H4 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 chenodeoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Chenodeoxycholic Acid results in increased expression of SLC51B mRNA and Chenodeoxycholic Acid results in increased expression of SLC51B protein CTD PMID:16423920 more ... chlorpromazine multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 cholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Cholic Acid results in increased expression of SLC51B mRNA CTD PMID:25055961 cholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Cholic Acid results in increased expression of SLC51B mRNA CTD PMID:22961653 and PMID:25582706 cholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cholic Acid binds to and results in increased activity of NR1H4 protein] which results in increased expression of SLC51B mRNA CTD PMID:22540009 choline multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC51B mRNA CTD PMID:20938992 chromium(6+) affects expression ISO Slc51b (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SLC51B mRNA CTD PMID:28472532 ciprofloxacin decreases expression ISO Slc51b (Mus musculus) 6480464 Ciprofloxacin results in decreased expression of SLC51B mRNA CTD PMID:24657338 cisplatin multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC51B mRNA CTD PMID:27392435 cisplatin increases expression ISO SLC51B (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC51B mRNA CTD PMID:27392435 clofibrate decreases expression ISO Slc51b (Mus musculus) 6480464 Clofibrate results in decreased expression of SLC51B mRNA CTD PMID:28973556 cyclosporin A increases expression ISO SLC51B (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC51B mRNA CTD PMID:20106945 more ... cyclosporin A decreases expression ISO SLC51B (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC51B mRNA CTD PMID:25562108 more ... cyclosporin A multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of SLC51B mRNA and [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA CTD PMID:27344345 and PMID:32152650 DDE decreases expression ISO Slc51b (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC51B mRNA CTD PMID:28392238 deoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Deoxycholic Acid results in increased expression of SLC51B and Deoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:22268002 and PMID:25055961 deoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 deoxycholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Deoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:21914718 and PMID:25582706 deoxycholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in increased expression of SLC51B mRNA] CTD PMID:21914718 dexamethasone multiple interactions EXP 6480464 [Dexamethasone binds to NR3C1 protein] which results in increased expression of SLC51B mRNA CTD PMID:19562681 dexamethasone increases expression ISO SLC51B (Homo sapiens) 6480464 Dexamethasone results in increased expression of SLC51B mRNA CTD PMID:19562681 dextran sulfate multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B mRNA CTD PMID:29950665 dibenzofurans decreases expression ISO Slc51b (Mus musculus) 6480464 Dibenzofurans results in decreased expression of SLC51B mRNA CTD PMID:34254344 dioxygen increases expression ISO SLC51B (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC51B mRNA CTD PMID:24703425 epoxiconazole decreases expression ISO Slc51b (Mus musculus) 6480464 epoxiconazole results in decreased expression of SLC51B mRNA CTD PMID:35436446 ethyl methanesulfonate decreases expression ISO SLC51B (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC51B mRNA CTD PMID:23649840 fidaxomicin multiple interactions ISO SLC51B (Homo sapiens) 6480464 Fidaxomicin inhibits the reaction [[SLC51A protein binds to SLC51B protein] which results in increased uptake of Glycochenodeoxycholic Acid] more ... CTD PMID:32294204 fipronil increases expression ISO SLC51B (Homo sapiens) 6480464 fipronil results in increased expression of SLC51B mRNA CTD PMID:27091632 fipronil multiple interactions ISO SLC51B (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of SLC51B mRNA CTD PMID:27091632 folic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC51B mRNA CTD PMID:20938992 folic acid decreases expression ISO Slc51b (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC51B mRNA CTD PMID:25629700 glycochenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 and PMID:32294204 glycocholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 and PMID:32294204 glycodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA more ... CTD PMID:32152650 glycyrrhetinate multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 glycyrrhetinic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 glycyrrhizinic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 GW 4064 multiple interactions ISO Slc51b (Mus musculus) 6480464 [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in increased expression of SLC51B mRNA more ... CTD PMID:20091679 more ... GW 4064 increases expression ISO SLC51B (Homo sapiens) 6480464 GW 4064 results in increased expression of SLC51B mRNA CTD PMID:22178739 GW 4064 increases expression ISO Slc51b (Mus musculus) 6480464 GW 4064 results in increased expression of SLC51B mRNA CTD PMID:23178280 more ... GW 4064 multiple interactions ISO SLC51B (Homo sapiens) 6480464 epigallocatechin gallate inhibits the reaction [GW 4064 results in increased expression of SLC51B mRNA] CTD PMID:22178739 hydrogen peroxide affects expression ISO SLC51B (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC51B mRNA CTD PMID:20044591 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC51B mRNA CTD PMID:21396975 L-methionine multiple interactions ISO Slc51b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC51B mRNA CTD PMID:20938992 lead(0) affects methylation ISO SLC51B (Homo sapiens) 6480464 Lead affects the methylation of SLC51B gene CTD PMID:31636367 leflunomide increases expression ISO SLC51B (Homo sapiens) 6480464 leflunomide results in increased expression of SLC51B mRNA CTD PMID:28988120 lithocholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Lithocholic Acid results in increased expression of SLC51B mRNA CTD PMID:19562681 and PMID:25055961 lithocholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Lithocholic Acid results in increased expression of SLC51B mRNA CTD PMID:17256725 and PMID:23034213 lithocholic acid multiple interactions EXP 6480464 [Lithocholic Acid binds to VDR protein] which affects the expression of SLC51B mRNA CTD PMID:19562681 lithocholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 NR1H3 protein inhibits the reaction [Lithocholic Acid results in increased expression of SLC51B mRNA] and SMAD3 protein promotes the reaction [Lithocholic Acid results in increased expression of SLC51B mRNA] CTD PMID:17256725 and PMID:23034213 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC51B mRNA CTD PMID:28801915 mercury dichloride decreases expression ISO Slc51b (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of SLC51B mRNA CTD PMID:31175882 methyl methanesulfonate decreases expression ISO SLC51B (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC51B mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO Slc51b (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of SLC51B mRNA CTD PMID:31175882 methyltestosterone multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of SLC51B mRNA CTD PMID:27344345 metronidazole decreases expression ISO Slc51b (Mus musculus) 6480464 Metronidazole results in decreased expression of SLC51B mRNA CTD PMID:24657338 N,N-diethyl-m-toluamide multiple interactions ISO SLC51B (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of SLC51B mRNA CTD PMID:27091632 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC51B mRNA CTD PMID:28801915 nefazodone multiple interactions ISO SLC51B (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SLC51B mRNA CTD PMID:32152650 neomycin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA CTD PMID:24657338 obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:27255380 obeticholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:27939613 obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA] CTD PMID:27255380 obeticholic acid increases expression ISO Slc51b (Mus musculus) 6480464 obeticholic acid results in increased expression of SLC51B mRNA CTD PMID:26655953 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of SLC51B mRNA CTD PMID:30449730 oleanolic acid increases expression ISO Slc51b (Mus musculus) 6480464 Oleanolic Acid results in increased expression of SLC51B mRNA and Oleanolic Acid results in increased expression of SLC51B protein CTD PMID:23948738 PCB138 multiple interactions ISO Slc51b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 perfluorobutanesulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorobutanesulfonic acid CTD PMID:26001962 perfluorohexanesulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorohexanesulfonic acid CTD PMID:26001962 perfluorooctane-1-sulfonic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased transport of perfluorooctane sulfonic acid CTD PMID:26001962 perfluorooctane-1-sulfonic acid increases expression ISO SLC51B (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of SLC51B mRNA CTD PMID:32253466 perfluorooctanoic acid increases expression ISO SLC51B (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SLC51B mRNA CTD PMID:32253466 phenethyl caffeate multiple interactions ISO Slc51b (Mus musculus) 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SLC51B mRNA and GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SLC51B mRNA] CTD PMID:28223344 phenobarbital increases expression ISO SLC51B (Homo sapiens) 6480464 Phenobarbital results in increased expression of SLC51B mRNA and Phenobarbital results in increased expression of SLC51B protein CTD PMID:19084549 and PMID:35881160 pirinixic acid increases expression ISO Slc51b (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC51B mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO Slc51b (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC51B mRNA CTD PMID:23811191 pirinixic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC51B mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC51B mRNA CTD PMID:19710929 prothioconazole decreases expression ISO Slc51b (Mus musculus) 6480464 prothioconazole results in decreased expression of SLC51B mRNA CTD PMID:36007749 Prothioconazole-desthio decreases expression ISO Slc51b (Mus musculus) 6480464 prothioconazole-desthio results in decreased expression of SLC51B mRNA CTD PMID:36007749 pyrazinecarboxamide multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Pyrazinamide results in decreased expression of SLC51B mRNA] CTD PMID:27255380 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLC51B mRNA and Pyrazinamide results in decreased expression of SLC51B protein CTD PMID:27255380 quercetin decreases expression ISO SLC51B (Homo sapiens) 6480464 Quercetin results in decreased expression of SLC51B mRNA CTD PMID:21632981 resorcinol decreases expression ISO SLC51B (Homo sapiens) 6480464 resorcinol results in decreased expression of SLC51B mRNA CTD PMID:22623647 resveratrol multiple interactions ISO SLC51B (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC51B mRNA CTD PMID:23557933 rifampicin increases expression ISO SLC51B (Homo sapiens) 6480464 Rifampin results in increased expression of SLC51B mRNA CTD PMID:27199754 serpentine asbestos increases expression ISO SLC51B (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of SLC51B mRNA CTD PMID:21148743 silicon dioxide decreases expression ISO SLC51B (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SLC51B mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO SLC51B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC51B mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO Slc51b (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC51B mRNA CTD PMID:37682722 streptozocin multiple interactions ISO Slc51b (Mus musculus) 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of SLC51B mRNA CTD PMID:29382564 taurochenodeoxycholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurochenodeoxycholic Acid more ... CTD PMID:32294204 taurocholic acid multiple interactions ISO SLC51B (Homo sapiens) 6480464 [SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurocholic Acid and Fidaxomicin inhibits the reaction [[SLC51A protein binds to SLC51B protein] which results in increased uptake of Taurocholic Acid] CTD PMID:32294204 tauroursodeoxycholic acid multiple interactions ISO Slc51b (Mus musculus) 6480464 [ursodoxicoltaurine co-treated with 1-Naphthylisothiocyanate] results in increased expression of SLC51B protein CTD PMID:36787806 tetrachloromethane decreases expression ISO Slc51b (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC51B mRNA CTD PMID:31919559 titanium dioxide multiple interactions ISO Slc51b (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B mRNA CTD PMID:29950665 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC51B mRNA CTD PMID:33387578 triclosan decreases expression ISO SLC51B (Homo sapiens) 6480464 Triclosan results in decreased expression of SLC51B mRNA CTD PMID:30510588 triclosan increases expression ISO SLC51B (Homo sapiens) 6480464 Triclosan results in increased expression of SLC51B mRNA CTD PMID:34681664 tris(2-butoxyethyl) phosphate affects expression ISO SLC51B (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC51B mRNA CTD PMID:29024780 ursodeoxycholic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Ursodeoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:25055961 ursodeoxycholic acid increases expression ISO Slc51b (Mus musculus) 6480464 Ursodeoxycholic Acid results in increased expression of SLC51B mRNA CTD PMID:25582706 valproic acid increases expression ISO SLC51B (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC51B mRNA CTD PMID:29154799